Pediatrix confirms stable payor mix and reaffirms 2026 Adjusted EBITDA outlook
The company reported stable payor mix metrics and reaffirmed its FY2026 adjusted EBITDA forecast of $280M to $300M. Management stated it remains on track despite sector-wide reports and will host an earnings call on August 4.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day